34501-55-8

Usage

InChI:InChI=1/C18H12O/c1-2-4-14-11(3-1)5-6-12-10-16-13(9-15(12)14)7-8-17-18(16)19-17/h1-10,17-18H

Upstream product

• 34501-53-6 1a,2,3,11b-tetrahydrobenz<5,6>anthra<1,2-b>oxirene 
• 77515-38-9 ((1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexyloxy)-acetic acid (8S,9S)-9-bromo-8,9,10,11-tetrahydro-benzo[a]anthracen-8-yl ester 
• 77515-39-0 (8S,9S)-9-Bromo-8,9,10,11-tetrahydro-benzo[a]anthracen-8-ol 
• 77515-40-3 Acetic acid (8S,9S)-9-bromo-8,9,10,11-tetrahydro-benzo[a]anthracen-8-yl ester 
• 34501-52-5 8,9,10,11-Tetrahydrobenzanthracen-8,9-bromhydrin 
• 77515-41-4 Acetic acid (8S,9S)-9,11-dibromo-8,9,10,11-tetrahydro-benzo[a]anthracen-8-yl ester 

Relevant academic research and scientific papers

1a,11b-Dihydrobenzanthrazirine. A non K-Region Polycylic Arene Imine

The synthesis of the title compound is described.Benzanthracene 8,9-oxide (6) was reacted with sodium azide in aqueous acetone and the trans-9-azido-8,9-dihydrobenzanthr-8-ol (7), so formed, was cyclized by tri-n-butylphosphine.Attempts to dehydroge

Synthesis and Absolute Stereochemistry of (+)- and (-)-BenzAnthracene 8,9-Oxide and Derived Mammalian liver Metabolites of BenzAnthracene

Benzanthracene 8,9-oxide, (5), a major initial metabolite of benzanthracene, has been synthesised in optically pure form.The (-)-enantiomer has been unequivocally assigned as by configurational correlation with (+)-trans-9S-bromo-8S-(menthyl